Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.37
-$0.05-1.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.51M | 10.63M | 11.18M | 11.86M | 10.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.15M | 50.13M | 47.11M | 49.32M | 40.81M |
| Operating Income | -42.15M | -50.13M | -47.11M | -49.32M | -40.81M |
| Income Before Tax | -84.50M | -45.44M | -41.91M | -44.35M | -35.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.50M | -45.44M | -41.91M | -44.35M | -35.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.50M | -45.44M | -41.91M | -44.35M | -35.81M |
| EBIT | -42.15M | -50.13M | -47.11M | -49.32M | -40.81M |
| EBITDA | -41.47M | -49.35M | -46.40M | -48.71M | -40.25M |
| EPS Basic | -1.77 | -0.95 | -0.88 | -1.02 | -0.87 |
| Normalized Basic EPS | -0.50 | -0.59 | -0.55 | -0.64 | -0.55 |
| EPS Diluted | -1.77 | -0.95 | -0.88 | -1.02 | -0.87 |
| Normalized Diluted EPS | -0.50 | -0.59 | -0.55 | -0.64 | -0.55 |
| Average Basic Shares Outstanding | 47.85M | 47.83M | 47.66M | 43.34M | 41.00M |
| Average Diluted Shares Outstanding | 47.85M | 47.83M | 47.66M | 43.34M | 41.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |